Lisata Therapeutics Stock Price Prediction

LSTA Stock  USD 2.58  0.15  5.49%   
At this time, the RSI of Lisata Therapeutics' share price is approaching 42. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Lisata Therapeutics, making its price go up or down.

Oversold Vs Overbought

42

 
Oversold
 
Overbought
The successful prediction of Lisata Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Lisata Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Lisata Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(0.84)
EPS Estimate Current Year
(2.66)
EPS Estimate Next Year
(2.35)
Wall Street Target Price
14
EPS Estimate Current Quarter
(0.75)
Using Lisata Therapeutics hype-based prediction, you can estimate the value of Lisata Therapeutics from the perspective of Lisata Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Lisata Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Lisata because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Lisata Therapeutics after-hype prediction price

    
  USD 2.57  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Lisata Therapeutics Basic Forecasting Models to cross-verify your projections.
For information on how to trade Lisata Stock refer to our How to Trade Lisata Stock guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lisata Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
1.754.827.89
Details
2 Analysts
Consensus
LowTargetHigh
10.7711.8313.13
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.67-0.67-0.66
Details

Lisata Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Lisata Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lisata Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Lisata Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Lisata Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Lisata Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lisata Therapeutics' historical news coverage. Lisata Therapeutics' after-hype downside and upside margins for the prediction period are 0.13 and 5.64, respectively. We have considered Lisata Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
2.58
2.57
After-hype Price
5.64
Upside
Lisata Therapeutics is slightly risky at this time. Analysis and calculation of next after-hype price of Lisata Therapeutics is based on 3 months time horizon.

Lisata Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Lisata Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lisata Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lisata Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.17 
3.07
  0.01 
  0.02 
8 Events / Month
10 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.58
2.57
0.39 
4,386  
Notes

Lisata Therapeutics Hype Timeline

Lisata Therapeutics is now traded for 2.58. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.02. Lisata is anticipated to decline in value after the next headline, with the price expected to drop to 2.57. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.39%, whereas the daily expected return is now at -0.17%. The volatility of related hype on Lisata Therapeutics is about 2380.82%, with the expected price after the next announcement by competition of 2.60. About 19.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.64. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Lisata Therapeutics recorded a loss per share of 2.51. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 15th of September 2022. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days.
Check out Lisata Therapeutics Basic Forecasting Models to cross-verify your projections.
For information on how to trade Lisata Stock refer to our How to Trade Lisata Stock guide.

Lisata Therapeutics Related Hype Analysis

Having access to credible news sources related to Lisata Therapeutics' direct competition is more important than ever and may enhance your ability to predict Lisata Therapeutics' future price movements. Getting to know how Lisata Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lisata Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
LIXTLixte Biotechnology Holdings 0.03 3 per month 5.42  0.03  7.24 (8.00) 70.38 
HSTOHistogen 0.00 0 per month 0.00 (0.06) 4.76 (4.55) 131.40 
IMNNImunon Inc(0.01)6 per month 0.00 (0.10) 4.65 (6.02) 24.06 
KAKineta Inc 0.20 3 per month 0.00 (0.04) 10.45 (10.00) 41.46 
RZLTRezolute 0.22 9 per month 0.00 (0.08) 5.54 (5.54) 16.12 
CYTCyteir Therapeutics 0.09 2 per month 2.57  0.09  10.00 (5.26) 36.14 
XOMAOXOMA Corporation 0.00 0 per month 0.01 (0.08) 0.51 (0.39) 2.44 
PTIXProtagenic Therapeutics 0.06 3 per month 0.00 (0.04) 14.29 (12.50) 48.67 
TPSTTempest Therapeutics(0.02)5 per month 0.00 (0.18) 5.38 (8.42) 29.55 
PULMPulmatrix 1.01 6 per month 3.57  0.19  16.69 (4.98) 92.85 
ONTXOnconova Therapeutics 0.00 0 per month 4.35  0.09  7.69 (8.33) 66.73 
CBIOCatalyst Biosciences 0.01 2 per month 4.45  0.15  9.76 (8.33) 38.47 
BPTHBio Path Holdings(0.01)7 per month 0.00 (0.08) 6.90 (7.76) 51.22 
MBRXMoleculin Biotech 0.02 10 per month 4.73 (0.01) 12.70 (9.68) 35.41 
ALPNAlpine Immune Sciences 0.00 0 per month 1.74  0.21  8.04 (4.04) 15.28 
ANTXAN2 Therapeutics 0.03 7 per month 2.03  0.11  6.34 (4.52) 28.89 
AMPEAmpio Pharm 0.00 0 per month 4.69  0.02  13.04 (8.70) 35.34 
GLUEMonte Rosa Therapeutics 0.84 9 per month 4.34  0.06  8.40 (8.46) 103.72 
CADLCandel Therapeutics(0.02)8 per month 5.95  0.02  10.61 (8.71) 99.24 

Lisata Therapeutics Additional Predictive Modules

Most predictive techniques to examine Lisata price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lisata using various technical indicators. When you analyze Lisata charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Lisata Therapeutics Predictive Indicators

The successful prediction of Lisata Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Lisata Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Lisata Therapeutics based on analysis of Lisata Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Lisata Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lisata Therapeutics's related companies.
 2023 2024 (projected)
Payables Turnover0.07810.0742
Days Of Inventory On Hand4.4K4.6K

Story Coverage note for Lisata Therapeutics

The number of cover stories for Lisata Therapeutics depends on current market conditions and Lisata Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Lisata Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Lisata Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Lisata Therapeutics Short Properties

Lisata Therapeutics' future price predictability will typically decrease when Lisata Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Lisata Therapeutics often depends not only on the future outlook of the potential Lisata Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lisata Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding8.1 M
Cash And Short Term Investments50.5 M

Complementary Tools for Lisata Stock analysis

When running Lisata Therapeutics' price analysis, check to measure Lisata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lisata Therapeutics is operating at the current time. Most of Lisata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lisata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lisata Therapeutics' price. Additionally, you may evaluate how the addition of Lisata Therapeutics to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Share Portfolio
Track or share privately all of your investments from the convenience of any device